Navigation Links
InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
Date:8/6/2009

enses

    -- R&D expense:  anticipated to be in a range of approximately $90 to
       $100 million, net of development cost reimbursements under the Roche
       collaboration.  Of this amount, approximately 60 percent is
       attributed to pirfenidone which includes expenses for CAPACITY, RECAP,
       the preparation and support of NDA and MAA submissions and
       manufacturing.

       Approximately 35 percent of the R&D expense is attributed to the
       company's one-third share of all development expenses incurred by the
       collaboration with Roche on ITMN-191.  The balance of 2009 R&D expense
       is related to the advancement of a named pirfenidone analog compound,
       ITMN-520, toward an expected IND filing in mid-2010.

    -- G&A expense: anticipated to be in a range of approximately $35 to $40
       million.  The G&A guidance range includes approximately $5.0 million of
       various pirfenidone pre-launch costs.

Conference Call and Webcast Details

InterMune will host a conference call today at 4:30 p.m. EDT to discuss its financial results for its second quarter and first six months of 2009, its forward-looking financial guidance and its clinical development programs. Interested investors and others may participate in the conference call by dialing 888-799-0528 (U.S.) or 973-200-3372 (international), conference ID# 22196018. A replay of the webcast and teleconference will be available approximately three hours after the call.

To access the webcast, please log on to the company's website at www.intermune.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.

The teleconference replay will be available approximately three hours after the call. The teleconference replay will be available for 10 business days following
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. InterMune to Release Second Quarter Financial Results on August 6
2. InterMune to Present at Goldman Sachs Healthcare Conference
3. InterMune Reports First Quarter 2009 Financial Results and Business Highlights
4. InterMune to Release First Quarter Financial Results on April 30
5. InterMune and Pharmasset to Discuss INFORM-1 Results From EASL Conference, April 25
6. InterMune to Present at Canaccord Adams Hepatitis C Conference
7. InterMune to Present at Citis 4th Annual Biotech Day
8. InterMune to Present Abstracts on HCV Protease Inhibitor ITMN-191 and HCV Development Program at the EASL Meeting
9. InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights
10. InterMune to Release Fourth Quarter, Full Year 2008 Financial Results on February 26
11. InterMune Announces Issuance of U.S. Patent for ITMN-191
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Carahsoft and CDS Federal Services have scheduled ... 2pm EST (11am PST), “Natural Language Processing: Converting Raw ... technology can turn raw, heterogeneous data into actionable knowledge ... online webinar will last approximately one hour. , Synopsis: ...
(Date:1/14/2014)... New York, NY (PRWEB) January 14, 2014 ... coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua is an ... products to serve the wound care market. , Free ... Alliqua was restructured with a seasoned management team and ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 In recent ... motives and methods in product development and promotion has ... industry. This mistrust, fueled by concerns about the insidious ... by reports of spectacular fines to the world’s biggest ...
(Date:1/14/2014)... Bellingham, Washington, USA, and Cardiff, UK (PRWEB) January 13, ... and photonics technology development leader with more than 20 ... international society for optics and photonics . Hainsey will ... “We are delighted to have Dr. Hainsey join SPIE ...
Breaking Biology Technology:Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2
... Kauten. Source: Teresa Esser. Ralph is one of the ... bioscience, said Frank Langley, president and CEO of Point One ... to admit that his success in high-tech entrepreneurship is somehow ... said in an interview. Ive been a lucky guy. , ...
... Wisconsin could lose its carefully established position as ... more money is not channeled into academic and other research ... the report (5.4 MB PDF) This prediction comes ... the governor on technological matters. The report, titled The Economic ...
... The difficult part is finding meaning. When researching the ... of information. , ,The differences between information and intelligence ... process for gathering information ensures that the results will ... well-defined purpose allows you to search the Internet broadly ...
Cached Biology Technology:Ralph Kauten on how to raise angel financing 2Ralph Kauten on how to raise angel financing 3Ralph Kauten on how to raise angel financing 4Economic report raises red flags on Wisconsin's future 2Economic report raises red flags on Wisconsin's future 3Are you gathering information or intelligence about competitors? 2Are you gathering information or intelligence about competitors? 3
(Date:7/9/2014)... PA, July 10, 2014 Inflammatory diseases can ... patient, complicating treatment because a medication effective for ... example is the anti-arthritic medication dexamethasone, which alleviates ... A study in the August issue of ... effects of a new class of anti-arthritic drugs, ...
(Date:7/9/2014)... found in the bladders of healthy women differ ... of incontinence, according to researchers from Loyola University ... findings, published July 9, 2014, in the American ... suggest that bacterial communities may play a role ... (UUI) is a common, yet poorly understood, condition ...
(Date:7/9/2014)... ranges in which animals can be found, concern mounts ... an increased range for a host mean new territory ... a team of UC Santa Barbara scientists, including parasitologists ... in the Journal of Biogeography , Hechinger, Kuris ... may happen: Hosts may actually lose their parasites when ...
Breaking Biology News(10 mins):New class of anti-arthritis drugs effectively treats multiple inflammatory diseases 2Not at home on the range 2Not at home on the range 3Not at home on the range 4
... This release is available in French . ... on an extremely important process for the proper functioning ... transportation pathway of ,cargo, to and from the surface ... have severe consequences, leading to numerous diseases such as ...
... French . , Qubec City, March ... surfaces are believed to be ineffective in eliminating noroviruses, ... of all foodborne gastroenteritis outbreaks. According to a recent ... Journal of Food Protection , only bleach-based disinfectants drastically ...
... New Orleans, LA Research led by Wayne L. Backes, ... LSU Health Sciences Center New Orleans School of Medicine, has ... are present in an individual, but also how they interact, ... is safely eliminated from the body or is converted into ...
Cached Biology News:Getting turned on 2Getting turned on 340 percent of surface disinfectants ineffective in eliminating viruses that cause gastroenteritis 2LSUHSC research increases understanding of drug metabolism 2
Molecular Biological Resources has extensive abilities cloning and expression of prokaryotic and eukaryotic proteins. Please contact lloconne@molbiores.com to discuss your project. Contact lloconne@...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
quantitation of phosphatase activity, evaluation of hits and leads from HTS...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: